Invitae Completes $40M Series E Financing | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic diagnostics firm Invitae today announced it completed a Series E financing round that raised $40 million.

The funds will go toward further development of the San Francisco-based company's clinical genetic tests for hereditary disorders, including oncology, cardiology, neurology, and pediatric medicine, it said, adding that it plans to expand into international markets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.